12 Health Care Stocks Moving In Friday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Friday's pre-market session, several healthcare stocks showed significant movement. Chromocell Therapeutics, Kineta, Portage Biotech, Erasca, MSP Recovery, and Cue Health were among the gainers, with increases ranging from 12.25% to 21.6%. On the downside, Nexalin Technology, iSpecimen, INVO Bioscience, Intelligent Bio Solutions, Trevena, and PaxMedica experienced declines between 9.58% and 18.4%. Notably, MSP Recovery and INVO Bioscience had recent earnings reports influencing their stock movements.
April 19, 2024 | 12:08 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Chromocell Therapeutics stock increased by 21.6% to $1.49, with a market cap of $8.7 million.
The significant pre-market increase in CHRO's stock price suggests positive investor sentiment, potentially due to company-specific news or broader sector movements.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Erasca stock rose 13.73% to $2.04, with a market cap of $308.4 million.
Erasca's notable increase in stock price indicates strong investor interest, possibly driven by recent company developments or favorable market conditions.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 90
POSITIVE IMPACT
Cue Health stock moved upwards by 12.25% to $0.16, with a market value of $25.2 million.
The increase in HLTH's stock price may reflect positive market reception to recent company news or achievements, suggesting potential short-term growth.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 90
POSITIVE IMPACT
MSP Recovery shares moved upwards by 13.25% to $0.94, after its Q4 earnings report.
The positive movement in LIFW's stock price post-earnings indicates favorable investor response to the financial results, suggesting optimism for short-term performance.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
INVO Bioscience stock decreased by 11.85% to $1.34, following its Q4 earnings report.
The decline in INVO's stock price post-earnings suggests the market's negative reaction to the reported financials, indicating potential short-term downside.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Nexalin Technology stock fell 18.4% to $1.2, with a market cap of $8.9 million.
The significant drop in NXL's stock price could be due to negative news or market sentiment, indicating potential short-term challenges.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90